- Organon press release ( NYSE: OGN ): Q2 Non-GAAP EPS of $1.25 beats by $0.06 .
- Revenue of $1.59B (flat Y/Y) beats by $60M .
- Full year 2022 financial guidance ranges updated:
- Revenues range narrowed to $6.1 billion to $6.3 billion from a prior outlook of $6.1B-$6.4B vs. $6.18B consensus, and reflects persisting foreign currency headwinds
- Adjusted EBITDA margin range now 32%-34% to incorporate acquired IPR&D and milestone expenses from recent business development
For further details see:
Organon Non-GAAP EPS of $1.25 beats by $0.06, revenue of $1.59B beats by $60M, lowers FY22 mid-point revenue guidance